Ibex Medical Analytics and LDPath have announced the rollout of the first clinical-grade artificial intelligence (AI) applications for pathology-based prostate cancer detection in the U.K. The new apps will aid in improving the accuracy and increasing the efficiency of cancer diagnostics, the companies said. Traditionally, cancer is diagnosed with the aid of a pathologist — an expert who will look at tissue samples under a microscope to identify changes associated with diseases. In recent years, the…
You must be logged in to read/download the full post.
The post First AI-based Cancer Detection Application Slated for UK Rollout appeared first on BioNewsFeeds.